Conmed (CNMD) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Conmed Corporation  (NYSE: CNMD)
 

Conmed Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Conmed's inventory turnover ratio sequentially decreased to 1.61 in the third quarter 2026, unsurprisingly, as the Conmed markets continue to deteriorate, and CNMD's faces growing challenges to bring down its inventories. Conmed's average inventory processing period in the Sep 30 2026 quarter, has increased to 227 days, from 217 days, in the Jun 30 2026 quarter.

Within Healthcare sector 252 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1545 in the second quarter 2026, to 1644.

CNMD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Conmed Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CNMD Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -0.42 % -0.57 % 3.22 % 2.55 % 6.37 %
Y / Y Cost of Sales Growth -14.78 % -5.19 % -6.9 % 4.95 % 24.76 %
Inventory Turnover Ratio (TTM) 1.61 1.68 1.7 1.74 1.73
CNMD's Total Ranking # 1644 # 1545 # 596 # 1034 #
Average inventory processing period 227 218 215 210 211
Seq. Inventory Growth 0.74 % -1.62 % 2.97 % -2.42 % 0.58 %
Seq. Cost of Sales Growth 0.26 % 9.3 % -13.76 % -9.83 % 11.54 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 253
Overall Market # 1644

Inventory Turnover Ratio Statistics
High Average Low
2.61 2.07 1.52
(Dec 31 2018)   (Dec 31 2011)



CNMD Company Profile >> Back to CNMD Efficiency Comparisons >> Compare CNMD Inventory Turnover Ratio to its Competitors

Financial Statements
Conmed's Inventories $ 363 Millions Visit CNMD's Balance sheet
Conmed's Cost of Revenues TTM $ 581 Millions Visit CNMD's Income Statement
What are CNMD's Sales? Visit CNMD's Sales by Segment

Other Inventory Turnover Ratios
Conmed's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CNMD's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CNMD's Competitors
Inventory Turnover Ratio for CNMD's Suppliers
Inventory Turnover Ratio for CNMD's Customers

You may also want to know
CNMD's Sales Growth Rates CNMD's Pe Price to earnings ratio CNMD's Receivables Turnover Ratio CNMD's Stock Quote
CNMD's Net Income Growth Rates CNMD's Ps Price to Sales ratio CNMD's Sales per Employee CNMD's Asset Turnover Ratio
CNMD's Net Margin CNMD's Pb Price to Book ratio CNMD's Financial Strength Ratios CNMD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Autolus Therapeutics Plc  4.34 $ 88.293  Millions$ 20  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Revvity Inc  2.93 $ 1,122.448  Millions$ 384  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Zai Lab Limited  2.91 $ 200.083  Millions$ 69  Millions
Amneal Pharmaceuticals Inc   2.90 $ 1,910.255  Millions$ 658  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Ani Pharmaceuticals Inc  2.87 $ 405.540  Millions$ 142  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Dentsply Sirona Inc   2.65 $ 1,769.000  Millions$ 668  Millions

Date modified: 2026-10-29T09:59:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.